Rationalizing combination therapies

Nature Medicine 23, 1113 (2017). doi:10.1038/nm.4426 A growing number of clinical trials on combination therapies raises the question of to what degree they may be redundant. Systems biology and hypothesis-driven preclinical studies could help to identify the most promising candidates for clinical trials, and also offer new insights into the biological mechanisms that underlie drug synergies.
Source: Nature Medicine - Category: General Medicine Tags: Editorial Source Type: research